BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38043126)

  • 21. A MC-based anthropomorphic test case for commissioning model-based dose calculation in interstitial breast 192-Ir HDR brachytherapy.
    Peppa V; Thomson RM; Enger SA; Fonseca GP; Lee C; Lucero JNE; Mourtada F; Siebert FA; Vijande J; Papagiannis P
    Med Phys; 2023 Jul; 50(7):4675-4687. PubMed ID: 37194638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of tetrahedral mesh geometries in Monte Carlo simulation of applicator based brachytherapy dose distributions.
    Fonseca GP; Landry G; White S; D'Amours M; Yoriyaz H; Beaulieu L; Reniers B; Verhaegen F
    Phys Med Biol; 2014 Oct; 59(19):5921-35. PubMed ID: 25210788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of dose calculation methods for brachytherapy of intraocular tumors.
    Rivard MJ; Chiu-Tsao ST; Finger PT; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Rogers DW; Thomson RM; Nath R
    Med Phys; 2011 Jan; 38(1):306-16. PubMed ID: 21361199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of patient inhomogeneities in oesophageal 192Ir HDR brachytherapy: a Monte Carlo and analytical dosimetry study.
    Anagnostopoulos G; Baltas D; Pantelis E; Papagiannis P; Sakelliou L
    Phys Med Biol; 2004 Jun; 49(12):2675-85. PubMed ID: 15272681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dosimetric study of Leipzig applicators.
    Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E; Soriano A; Crispín V
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):579-84. PubMed ID: 15890603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
    Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
    Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sub-second high dose rate brachytherapy Monte Carlo dose calculations with bGPUMCD.
    Hissoiny S; D'Amours M; Ozell B; Despres P; Beaulieu L
    Med Phys; 2012 Jul; 39(7):4559-67. PubMed ID: 22830787
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Hadadi A; Ghanavati S
    Appl Radiat Isot; 2023 Jul; 197():110786. PubMed ID: 37023694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric characterization of a novel intracavitary mold applicator for 192Ir high dose rate endorectal brachytherapy treatment.
    Poon E; Reniers B; Devic S; Vuong T; Verhaegen F
    Med Phys; 2006 Dec; 33(12):4515-26. PubMed ID: 17278803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the apex optimization line matter for single-channel vaginal cylinder brachytherapy planning?
    Kim Y; Cabel K; Sun W
    J Appl Clin Med Phys; 2018 Jul; 19(4):307-312. PubMed ID: 29766643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can intermediate-energy sources lead to elevated bone doses for prostate and head & neck high-dose-rate brachytherapy?
    Famulari G; Alfieri J; Duclos M; Vuong T; Enger SA
    Brachytherapy; 2020; 19(2):255-263. PubMed ID: 31964601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric impact of an 192Ir brachytherapy source cable length modeled using a grid-based Boltzmann transport equation solver.
    Mikell JK; Mourtada F
    Med Phys; 2010 Sep; 37(9):4733-43. PubMed ID: 20964191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of rib and lung heterogeneities on the computed dose to lung in Ir-192 high-dose-rate breast brachytherapy: Monte Carlo versus a treatment planning system.
    Yazdi HS; Shamsaei M; Jaberi R; Shabani HR; Allahverdi M; Vaezzadeh SA
    J Cancer Res Ther; 2012; 8(3):394-8. PubMed ID: 23174721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and evaluation of 3D printable patient-specific applicators for gynecologic HDR brachytherapy.
    Semeniuk O; Cherpak A; Robar J
    Med Phys; 2021 Jul; 48(7):4053-4063. PubMed ID: 33880777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
    Austerlitz C; Campos CA
    Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and characterization of a new high-dose-rate brachytherapy Valencia applicator for larger skin lesions.
    Candela-Juan C; Niatsetski Y; van der Laarse R; Granero D; Ballester F; Perez-Calatayud J; Vijande J
    Med Phys; 2016 Apr; 43(4):1639. PubMed ID: 27036563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
    Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
    Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of HDR near source dosimetry using a treatment planning system, Monte Carlo simulation, and radiochromic film.
    Amoush A; Luckstead M; Lamba M; Elson H; Kassing W
    Med Dosim; 2013; 38(2):160-4. PubMed ID: 23246195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity modulated Ir-192 brachytherapy using high-Z 3D printed applicators.
    Skinner LB; Niedermayr T; Prionas N; Perl J; Fahimian B; Kidd EA
    Phys Med Biol; 2020 Jul; 65(15):155018. PubMed ID: 32521512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monte Carlo investigation of dose distribution of uniformly and non-uniformly loaded standard and notched eye plaques.
    Semeniuk O; Malkov V; Chamberland MJP; Weersink RA
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14149. PubMed ID: 37738654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.